Clinical trial · Interventional
The ACURE Trial: Acupuncture for Colorectal Recovery
Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Purpose: The goal of this clinical trial is to evaluate whether electroacupuncture (EA) can accelerate the recovery of bowel function in patients undergoing minimally invasive surgery for colorectal cancer. Main Questions to be Answered: Does electroacupuncture reduce the time to the first bowel movement after surgery compared to standard care or a "sham" (placebo) treatment? Can electroacupuncture improve overall gastrointestinal tolerance and reduce postoperative discomfort? Study Design: Participants will be randomly assigned to one of three groups: Electroacupuncture Group: Receives active electrical stimulation at specific acupuncture points. Sham Acupuncture Group: Receives superficial needling at non-treatment points with no electrical current to serve as a placebo. Standard Care Group: Receives standard hospital recovery protocols (ERAS) without acupuncture. All treatments will consist of four 30-minute sessions: one before surgery and three on the days following the procedure. Researchers will compare the three groups to see if the electroacupuncture group experiences a faster return of digestive function.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Neoplasms | Colorectal Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Gastrointestinal Motility | — | UNRESOLVED | — |
| Ileus Postoperative | — | UNRESOLVED | — |
| Postoperative Complication | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Electroacupuncture (EA) | Device | — | UNRESOLVED |
| Enhanced Recovery After Surgery (ERAS) Protocol | Procedure | — | UNRESOLVED |
| Sham Electroacupuncture (SA) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Electroacupuncture (EA) Group
- description
- Participants receive active electroacupuncture at bilateral acupoints ST36, ST37, SP6, LI4, and PC6. A continuous wave frequency of 5 Hz is applied for 30 minutes. Treatment occurs once daily: one session on preoperative day 1 and three sessions on postoperative days 1 to 3.
- interventionNames
- Device: Electroacupuncture (EA)
- Procedure: Enhanced Recovery After Surgery (ERAS) Protocol
- type
- SHAM_COMPARATOR
- label
- Sham Electroacupuncture (SA) Group
- description
- Participants receive superficial needling (2-3 mm depth) at five non-acupoint locations. Electrodes are attached to a disconnected electroacupuncture device (no current delivered). The treatment schedule and duration (30 mins) are identical to the EA group
- interventionNames
- Device: Sham Electroacupuncture (SA)
- Procedure: Enhanced Recovery After Surgery (ERAS) Protocol
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed colorectal cancer requiring scheduled curative-intent resection. * Age between 18 and 79 years, inclusive. * Ability to understand the study protocol and provide written informed consent. * American Society of Anesthesiologists (ASA) physical status classification of I, II, or III. Exclusion Criteria: * Pregnant or breastfeeding women. * History of major abdominal surgery within the past 4 weeks. * Receipt of chemotherapy or radiotherapy within the past 6 months. * History of organ transplantation with rejection episodes within the past 30 days. * Presence of active infection (e.g., tuberculosis, sepsis, peritonitis). * Positive for hepatitis B, hepatitis C, or HIV with an uncontrolled viral load. * Severe malnutrition, defined as a Nutritional Risk Screening (NRS 2002) score ≥ 3. * History of total colectomy or requirement for ileorectal anastomosis. * Requirement for multivisceral resection due to tumor invasion. * Scheduled for prophylactic stoma creation. * Moderate to severe cognitive impairment, epilepsy, or uncontrolled neurological disorders. * Active psychiatric illness (e.g., bipolar disorder, schizophrenia) that may interfere with study compliance. * Severe cardiopulmonary insufficiency (e.g., New York Heart Association \[NYHA\] class IV heart failure or requirement for long-term oxygen therapy). * Presence of open wounds, skin infections, or known allergies at or near the designated acupuncture sites. History of adverse reactions to acupuncture, including syncope (fainting) or needle phobia. Participation in another clinical trial within the past 6 months. Anticipated inability to complete the study protocol due to physical, psychological, or logistical reasons.
References
Publications (0)
Data not yet available